UW-Madison NeuCode Labeling Technique Could Significantly Up Mass Spec Multiplexing for Proteomics
HTTP/1.1 200 OK Server: Apache/2.2.3 (CentOS) X-Powered-By: PHP/5.2.17 Expires: Sun, 19 Nov 1978 05:00:00 GMT Last-Modified: Sat, 02 Mar 2013 09:23:09 GMT Cache-Control: store, no-cache, must-revalidate Cache-Control: post-check=0, pre-check=0 Vary: Accept-Encoding Content-Type: text/html; charset=utf-8 Content-Length: 38759 Date: Sat, 02 Mar 2013 09:23:09 GMT X-Varnish: 1328552054 Age: 0 Via: 1.1 varnish Connection: keep-alive
UW-Madison NeuCode Labeling Technique Could Significantly Up Mass Spec Multiplexing for Proteomics | GenomeWebUW-Madison NeuCode Labeling Technique Could Significantly Up Mass Spec Multiplexing for Proteomics
March 01, 2013
Existing premium subscribers
login here.
New to GenomeWeb?
Register herequickly.
| Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail This email address is being protected from spambots. You need JavaScript enabled to view it. and follow his GenomeWeb Twitter account at @ProteoMonitor. |
-
An international team led by investigators at the Michigan State University and the University of Kentucky have
sequenced and assembled the genome of sea lamprey, Petromyzon marinus, using the sequence to begin refining their understanding of vertebrate evolution. Their work was published online this week in
Nature Genetics. The team's analyses of the 816 million base genome assembly uncovered 26,046 predicted protein-coding genes.
-
Promega is
suing Life Technologiesin federal court saying the Carlsbad, Calif.-based company infringes patents held by Promega covering the analysis of small tandem repeat loci for genetic analysis. In its complaint filed in US District Court Western District of Wisconsin, Promega alleges Life Tech and its Applied Biosystems business infringe US Patent No. RE37984 through the sale of AuthentiFiler products. In December, Life Tech sued Promega over the same patent.
-
After more than a year of on-and-off again negotiations, members of Congress and the White House have failed to reach a compromise agreement to
avert the budget sequester penalty, which will slash $85 billion out of federal discretionary spending this fiscal year. Sequestration was set to take effect on Friday. The National Institutes of Health, the National Science Foundation, the Food and Drug Administration, and all other federal agencies must begin enacting 5 percent budget cuts.
-
The
legend of the swan songhas taken hold as a metaphor for a last act before the end. Though this issue of
Genome Technologyis its swan song, it goes out facing the future, with profiles of two dozen up-and-coming investigators intent on making their mark on the life sciences community in fields as varied as clinical cancer sequencing and gene splicing and public health genomics. Their best days are likely ahead, even as
GT's days end.